Kouko Tatsumi1*
Ayami Isonishi1
Miwako Yamasaki2Yoshie Kawabe1Shoko Morita-Takemura1Kazuki Nakahara1Yuki Terada3Takeaki Shinjo3Hiroaki Okuda4Tatsuhide Tanaka1
Akio Wanaka1- 1Department of Anatomy and Neuroscience, Faculty of Medicine, Nara Medical University, Kashihara, Japan
- 2Department of Anatomy, Hokkaido University Graduate School of Medicine, Hokkaido University, Sapporo, Japan
- 3Department of Anesthesiology, Faculty of Medicine, Nara Medical University, Kashihara, Japan
- 4Department of Functional Anatomy, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
Astrocytes are the most abundant glia cell type in the central nervous system (CNS), and are known to constitute heterogeneous populations that differ in their morphology, gene expression and function. Although glial fibrillary acidic protein (GFAP) is the cardinal cytological marker of CNS astrocytes, GFAP-negative astrocytes can easily be found in the adult CNS. Astrocytes are also allocated to spatially distinct regional domains during development. This regional heterogeneity suggests that they help to coordinate post-natal neural circuit formation and thereby to regulate eventual neuronal activity. Here, during lineage-tracing studies of cells expressing Olig2 using Olig2CreER; Rosa-CAG-LSL-eNpHR3.0-EYFP transgenic mice, we found Olig2-lineage mature astrocytes in the adult forebrain. Long-term administration of tamoxifen resulted in sufficient recombinant induction, and Olig2-lineage cells were found to be preferentially clustered in some adult brain nuclei. We then made distribution map of Olig2-lineage astrocytes in the adult mouse brain, and further compared the map with the distribution of GFAP-positive astrocytes visualized in GFAPCre; Rosa-CAG-LSL-eNpHR3.0-EYFP mice. Brain regions rich in Olig2-lineage astrocytes (e.g., basal forebrain, thalamic nuclei, and deep cerebellar nuclei) tended to lack GFAP-positive astrocytes, and vice versa. Even within a single brain nucleus, Olig2-lineage astrocytes and GFAP astrocytes frequently occupied mutually exclusive territories. These findings strongly suggest that there is a subpopulation of astrocytes (Olig2-lineage astrocytes) in the adult brain, and that it differs from GFAP-positive astrocytes in its distribution pattern and perhaps also in its function. Interestingly, the brain nuclei rich in Olig2-lineage astrocytes strongly expressed GABA-transporter 3 in astrocytes and vesicular GABA transporter in neurons, suggesting that Olig2-lineage astrocytes are involved in inhibitory neuronal transmission.
Introduction
The transcription factor Olig2 plays an essential role in the differentiation of oligodendrocytes and motor neurons in the embryonic spinal cord (Takebayashi et al., 2002; Zhou and Anderson, 2002), and in oligodendrocyte maturation in the developing ventral forebrain (Parras et al., 2007; Petryniak et al., 2007). One of the proposed major Olig2 functions is to generate oligodendrocytes by inhibiting astrocytic differentiation (Fukuda et al., 2004; Setoguchi and Kondo, 2004). In the last decade, a number of genetic fate-mapping studies using Olig2CreER mice have demonstrated that Olig2-positive cells (Olig2 cells) generate oligodendrocytes, astrocytes and neurons in the developing brain, and their differentiation properties vary in a brain region-specific manner (Miyoshi et al., 2007; Ono et al., 2008). These detailed studies support the concept that Olig2 cells form heterogeneous progenitor pools in the developing forebrain (Ono et al., 2008). In the adult brain, most Olig2 cells co-express NG2 proteoglycan and are termed adult oligodendrocyte progenitor cells (OPCs) (Goldman, 2003). They generate mainly OPCs/NG2 glia or mature oligodendrocytes and a subset of astrocytes, but not neurons (Dimou et al., 2008; Tatsumi et al., 2016). In injured or pathological states of the adult brain, Olig2 cells generate OPCs/NG2 glia, mature oligodendrocytes and a portion of reactive astrocytes, but, again, not neurons (Magnus et al., 2008; Tatsumi et al., 2008; Islam et al., 2009; Zhao et al., 2009; Guo et al., 2011; Shimizu et al., 2013). These genetic fate-mapping studies indicate that Olig2 cells mainly generate oligodendrocyte-lineage cells throughout life, while neurogenesis is limited in the embryonic stage and never occurs in the post-natal brain. The role of Olig2 in astrogliogenesis is much less well understood, because it has received little attention so far.
Recently, we found that Olig2-lineage astrocytes clustered in specific brain nuclei in the adult mouse (Tatsumi et al., 2016). During lineage-tracing studies of cells expressing Olig2 in Olig2CreER; ROSA-GAP43-EGFP mice (Tatsumi et al., 2008), we found that Olig2-lineage mature astrocytes preferentially cluster in the globus pallidus, which exerts pivotal functions in the indirect pathway of the basal ganglionic circuit. These experiments took advantage of the GAP43-EGFP fusion protein, whose targeted distribution to the plasma membrane allowed us to visualize cellular morphology in detail (e.g., the shapes of fine processes). GFP immunoelectron microscopy illustrated that immunoreactive fine processes elaborated arborization into the neuropil and attached to synaptic sites. Morphometric analyses revealed that astrocytic fine processes of the Olig2-lineage astrocytes underwent plastic changes that correlated with overall running activity, suggesting that they actively modulate motor functions (Tatsumi et al., 2016). In addition, we recently noticed that another reporter line (Ai39 mouse; see Materials and Methods) was very potent in illustrating detailed morphology of a recombined cell.
Neurotransmitter uptake is one of the important functions of astrocytes (Haydon, 2001). In the vast amount of brain excitatory synapses, astrocytes uptake excess amount of glutamate from synaptic clefts through glutamate transporters such as GLT-1 and GLAST (Chaudhry et al., 1995; Rothstein et al., 1996; Tanaka et al., 1997). Another important function of astrocytes is gliotransmission, although its functional significance is recently in dispute (Fiacco and McCarthy, 2018; Savtchouk and Volterra, 2018). For example, G-protein coupled receptor-regulated glutamate exocytosis has been demonstrated (Cali et al., 2014). In addition to the glutamate transporters, astrocytes are also known to express GABA transporter, GAT-3 (Fraser et al., 1994; Durkin et al., 1995). GAT-3 is mainly found in the retina, olfactory bulb (OB), and globus pallidus (Minelli et al., 1996; Jin et al., 2011a,b). In the basal ganglia, GAT-3 modulates neuronal activities in concert with another GABA transporter, GAT-1, which is primarily expressed in neurons (Kirmse et al., 2009; Galvan et al., 2010; Jin et al., 2011a). As in the case for gliotransmission of glutamate, GABA is also released from astrocytes through bestrophin channel (Lee et al., 2010). These findings imply that a subgroup of astrocytes may be subsidiary to inhibitory neuronal circuits by transporting GABA from and/or releasing GABA to synaptic clefts.
The fact that Olig2-lineage astrocytes clustered in specific brain nuclei prompted us to construct a distribution map of Olig2-lineage astrocytes in the whole brain. We also performed similar genetic marking of glial fibrillary acidic protein (GFAP)-positive astrocytes, and then compared the distribution pattern of Olig2-lineage astrocytes with that of GFAP-positive astrocytes. We found that these two populations of astrocytes were differentially distributed in the adult mouse brain. Olig2-lineage astrocytes tended to express GABA transporter-3 (GAT-3), and their fine processes frequently attached to synapses with vesicular GABA transporter-positive axon terminals. Based on the above data, we discuss possible functional implications of Olig2-lineage astrocytes.
Materials and Methods
Animals
We crossed Olig2 knock-in mice (Olig2KICreER) (Takebayashi et al., 2002) or GFAPCre mice (Garcia et al., 2004; Herrmann et al., 2008) with reporter mice Rosa-CAG-LSL-eNpHR3.0-EYFP (Ai39 mice, Jackson Laboratory, Stock No: 014539) to obtain Olig2KICreER/WT; Ai39 mice (hereafter termed Olig2CreER- Ai39 mice) and GFAPKICre; Ai39 mice (hereafter termed GFAPCre-Ai39 mice). In Ai39 mice, cre-inducible halorhodopsin (eNpHR3.0) fused with YFP at its C-terminus is driven by a specially designed expression cassette in a modified Rosa26 locus, which showed efficient and strong YFP fluorescence at the membrane (Madisen et al., 2009, 2012). The YFP is fused to the C-terminus of the halorhodopsin and is localized in the cytoplasmic side. It clearly revealed cellular morphology without YFP immunostaining. In the present study, we used theses double transgenic mice for immunofluorescence study.
We also crossed Olig2 knock-in mice (Olig2KICreER) and ROSA-GAP43-EGFP reporter line (Soriano, 1999) to obtain Olig2KICreER/WT; GAP43-EGFP mice (hereafter termed Olig2CreER-GFP mice). This reporter mice were particularly useful for visualizing the morphology of cells that underwent recombination, because GAP43-EGFP is a fusion protein between GFP and the N-terminus (amino acids 1–20) of GAP-43, which has been implicated in plasma membrane targeting through palmitoylation (Liang et al., 2002). Although the fluorescence of the GAP43-EGFP was generally weaker than that of the Ai39 reporter line, the moderate amount of the fusion protein was suitable for immunoelectron microscopic detection. Taking these experimental conditions into account, we employed Olig2CreER-, and GFAPCre-Ai39 mice for fluorescence microscopy and Olig2CreER-GFP mice were used for electron microscopy.
All the mice were maintained in a mixed genetic background; Olig2CreER-Ai39 mice (C57BL/6 and 129 S6/Sv strains), GFAPCre-Ai39 mice (C57BL/6 and FVB/N strains) and Olig2CreER-GFP mice (C57BL/6 and 129 X1/svJ strains). They were housed in standard cages under a 12 h light/dark cycle and temperature-controlled conditions. In the present study, we used 3–5 mice for each transgenic mouse strain and all the mice were 11 weeks old. All the protocols for the animal experiments were approved by the Animal Care Committee of Nara Medical University in accordance with the policies established in the NIH Guide for the Care and Use of Laboratory Animals.
Tamoxifen Administration
In the present study, we employed oral administration of tamoxifen. Tamoxifen (TM, Sigma Aldrich, Japan) was mixed with powdered chow (0.5 mg/g normal chow). Olig2CreER-Ai39 mice for immunofluorescence experiments were allowed to access the tamoxifen-containing chow ad libitum from 11 to 16 weeks old (see Figure 1A). This oral administration method is convenient for continuous administration and results in efficient induction of recombination while minimizing stress on the mice (Casanova et al., 2002; Kiermayer et al., 2007; Feil et al., 2009; Welle et al., 2009). Olig2CreER-GFP mice for immunoelectron microscopy were also fed with tamoxifen-containing chow as described above (see Figure 2A). All the mice appeared in healthy condition, although some mice were lost up to 10% of their body weight during the tamoxifen-fed period.
Figure 1. Olig2-lineage cells in the adult Olig2CreER-EYFP mice express astrocytic marker. (A) The experimental schedule of tamoxifen administration was depicted. Tamoxifen was orally administered (TAM feed) for 5 consecutive weeks and at the end of the 16th week, mice were sacrificed and subjected to analyses. (B) Low-magnification view of YFP-positive Olig2-lineage cells (green) and Nissl stain (red) in a sagittal brain section of Olig2CreER-YFP mice. (C–H) Double immunofluorescence with cell marker antibodies showed that Olig2-lineage bushy cells were positive for mature astrocytic marker: SOX9 (C1–C3; arrows), s100β (D1–D3; arrow), GS (E1–E3; arrows), 3-PGDH (F1–F3; arrows) in brain regions indicated. They were negative for mature oligodendrocyte marker, CC-1 (G1–G3; arrowhead), and NG2 (OPCs/NG2 glia marker, H1–H3; arrowheads) in their nuclei (G,H; arrows). LGP, lateral globus pallidus; VP, ventral pallidum; SI, substantia innominata; Th, thalamus; STh, subthalamic nucleus; ZI, zona incerta; APT, anterior pretectal nucleus; SC, superior colliculus; SN, substantia nigra; SOC, superior olivary complex; Mo5, motor trigeminal nucleus; DCN, deep cerebellar nuclei; VN, vestibular nuclei; 7N, facial nucleus; Sp5, spinal trigeminal nucleus. Scale bar: 1 mm (B), 20 μm (H3, for C–H).
Figure 2. Olig2-AS expressed low level of GFAP in the LGP and the SN. Olig2-AS co-expressed mature astrocytic marker SOX9 (arrow, A2), s100β (arrows, B2,C2) and GS (arrow, D2) in the LGP (A,B) and the SN (C,D). GFAP immunoreactive structures (arrowheads, A3–D3) were barely detected in the Olig2-AS territories (bordered with white dotted lines). Note that mature astrocyte markers (SOX9, s100β, and GS, arrowheads in A2–D2) were co-expressed with GFAP immunoreactivities (arrowheads in A4–D4). Scale bar (D5, for all panels): 20 μm.
Tissue Preparation and Immunofluorescence Experiments
Mice were perfused with 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS). Brains were removed and post-fixed in 4% PFA, and cryopreserved in 30% sucrose until they sank, and cryosections were cut at 30-μm thickness on a cryostat (Leica CM1860, Leica Microsystems, Japan). Immunofluorescence experiment was performed as described previously (Tatsumi et al., 2016). The primary antibodies were listed in the Table 1. Alexa-594- or 647-conjugated antibodies (1:1,000, Jackson ImmunoResearch, USA) were used as secondary antibodies. Blue-fluorescent Nissl stain (1:200, Neurotrace 435/455, ThermoFisher Scientific, Japan) was used as a counterstaining.
Table 1. List of primary antibodies used.
All the fluorescence images were obtained with a confocal laser scanning microscope (Nikon C2-NiE, Tokyo, Japan) as single planes or as z-stack projections (x-axis by y-axis, 1,024 by 1,024 pixels). For wide-field fluorescence images (e.g., half coronal section or whole sagittal section of mouse brain), we captured 50~80 images for whole area with 10 × objective lens (NA 0.45, UpanApo, Nikon) at 1.5 optical zoom by motorized x/y stage, and images were tiled to construct a large image. We obtained the z-stack multi-channel images at 1 μm intervals with 20 × objective lens (NA 0.75, UpanApo, Nikon) for the globus pallidus and the images generated orthogonal views (x-z and y-z planes) and a 3D rendering view (see Figures 3B,C). For high magnification images, we used 60 × water-immersion objective lens (NA 1.45, UpanApo, Nikon) at 1.5 optical zoom. All the images were processed by Nikon Nis-Elements software (version 4.11).
Figure 3. Olig2-AS and GFAP-immunoreactive astrocytes show differential localization in a single brain nucleus. In a low-magnification view, Olig2-AS (in green fluorescence) and GFAP-immunolabeled astrocytes (in red fluorescence) were densely localized in the LGP (A1,A2, respectively) and SOX9 immunoreactive astrocytes were more widely distributed in CPu and LGP (A3). (B) The orthogonal views (x-y, y-z, and x-z planes) revealed that SOX9 positive Olig2-AS (arrows) and SOX9 positive GFAP-expressing astrocytes (arrowheads) occupied adjacent but non-overlapping territories in the LGP. (C) The z-stack 3D images of the same area of (B). (D) Semi-quantitative analyses revealed that 88% (204/232, n = 3) of SOX9-positive YFP-positive Olig2-AS were GFAP-negative and 12% (28/232, n = 3) of them co-expressed GFAP. All the SOX9-positive YFP-negative cells in the LGP were positive for GFAP (281/281, n = 3). Scale bar (A3, for A1,A2): 100 μm.
The YFP intensity of each brain region in the low magnification images was measured using Nikon Nis-Elements software. To standardize the fluorescence intensities among different sections, the value of fluorescence intensity was divided by the value of background intensity, yielding a ratio. For objective evaluation of regional fluorescence, a researcher who was blind to the nature of an image performed measurements of regional fluorescence with the software and calculate the brain region/background ratios. We then classified these ratios into three groups (strong; larger than 20, moderate; 10–20, weak/absent; less than 10) and the groups were color-coded (strong; red, moderate; yellow, weak/absent; blue) for Table 2. For example, the panel B4 in the Figure 4 contained the regions of strong fluorescence such as the lateral septum (LS; 22.5) and the somatosensory cortex (S1BF; 28.6), the region of moderate fluorescence such as the motor cortex (M, 14.6) and the regions of weak or absent fluorescence such as the caudate putamen (CPu, 2.2). In the Table 2, it should be noted that the color-coded ratios were relative among the sections of each double transgenic line (i.e., Olig2CreER-Ai39 or GFAPCre-Ai39 mice) and could not be directly compared.
Table 2. Distribution of Olig2-AS and GFAP-AS in the adult mouse brain.
Figure 4. Distribution patterns of Olig2-AS and GFAP-AS in the adult Olig2CreER- and GFAPCre-Ai39 mice (olfactory bulb to forebrain). Illustrated brain sections with the names of brain nuclei are shown in a rostro-caudal order (A1–A5). The numerical values in the lower right corners indicate distance (mm) from the bregma. All the abbreviations of brain nuclei are according to the Mouse Brain Atlas in Stereotaxic Coordinates (Franklin and Paxinos, 1997) and are listed at the end of the main text. The distributions of Olig2- (B1–B5) and GFAP-AS (C1–C5) were compared in coronal sections of the same rostro-caudal position of Olig2CreER- and GFAPCre-Ai39 mice, respectively. All coronal sections were counterstained by Nissl, and identified brain nuclei are indicated in each section.
Immunoelectron Microscopy
Pre-embedding double immunoelectron microscopy was performed as described previously with a few modifications (Yamasaki et al., 2010). Vibratome sections were incubated in blocking solution (Aurion, Netherlands) for 30 min and then with a cocktail of primary antibodies (for GABAergic terminals; rabbit anti-GFP antibody and guinea pig anti-VGAT antibody, for glutamatergic terminals; rabbit anti-GFP antibody and guinea pig anti-VGluT1/2 antibodies) diluted with 1% BSA/ 0.002% saponin/PBS overnight. The sections were washed with 0.002% saponin/ PBS, incubated with 1.4 nm gold particles conjugated anti-guinea pig IgG (1:100, Nanoprobes, Stony Brook, NY) for 4 h. After washing, immunogold particles were intensified using a silver enhancement kit (R-Gent SE-EM; Aurion, Netherlands) for 60 min, washed, and incubated with peroxidase labeled anti-rabbit IgG (414341F, Nichirei Bioscience, Japan) for 4 h and visualized with chromogenic reaction of 3,3′-diaminozidine (DAB). Sections were further treated with 1% osmium tetroxide for 15 min on ice, stained by 2% uranyl acetate for 15 min.
In addition to the method described above, we performed another method of double immunoelectron microscopy. Briefly, vibratome sections were incubated a cocktail of primary antibodies (for GABAergic terminals; rat anti-GFP antibody and rabbit anti-VGAT antibody, for glutamatergic terminals; rat anti-GFP antibody and guinea pig anti-VGluT1/2 antibodies) diluted with 1% BSA/0.002% saponin/PBS overnight. The sections were washed, incubated with peroxidase-labeled anti-rat IgG (414311F, Nichirei Bioscience, Japan), and followed by DAB chromogenic reaction for GFP visualization. After washing, the sections were incubated either with biotinylated anti-rabbit antibody (BA-1000, Vector Laboratories, Japan, for GABA) or biotinylated anti-guinea pig antibody (BA-7000, Vector Laboratories, Japan, for glutamate), followed with peroxidase-labeled streptavidin (426061, Nichirei Bioscience, Japan) incubation, and then subjected to DAB chromogenic reaction again to visualize axon terminals with synaptic vesicles (VGAT or VGluT1/2 positive). Then, sections were treated with 1% osmium tetroxide for 60 min.
Although the latter DAB-DAB combination method yielded results comparable to those with immunogold-DAB method (see Figure 7), we found that the outlines of the DAB-labeled axon terminals were much easier to observe than those of the nanogold-labeled ones. We therefore employed the DAB combination method in semi-quantitative analyses of association between axon terminals and astrocytic fine processes (see below).
All the sections were dehydrated through a graded ethanol series, and flat-embedded in epoxy resin (Epon812 resin embedding kit, TAAB Laboratories Equipment, Japan). The resin was polymerized for 2 days at 60°C. We then carefully dissected out regions containing well-isolated GFP-positive bushy cells from a flat-embedded section under a light microscope (a representative image, inset in Figure 2B). The semi thin (1 μm) and ultrathin (70–80 nm) sections were cut on an ultramicrotome (Leica EM UC7, Leica Microsystems, Japan). The ultrathin sections were collected onto formvar-coated single whole grid, and observed under a JEOL transmission electron microscope (JEM-1400plus, JEOL, Japan).
In semi-quantitative analyses of association between axon terminals and astrocytic fine processes, a researcher took electron microscopic images that contained immunoreactive axon terminals (either VGAT-positive or VGluT1/2-positive) and astrocytic fine processes. Another researcher who was blind to the nature of vesicle transporter immunoreactions counted the numbers of immunoreactive terminals attached with astrocytic fine processes and the numbers of immunoreactive terminals without process attachments in the images. The counts were later summed and subjected to statistical analyses.
Results
The Adult Mouse Brain Contains Olig2-Lineage Astrocytes
Figure 1A showed the schedule of oral tamoxifen administration for Olig2CreER-Ai39 mice for immunofluorescence study. As shown in Figure 1B, continuous feeding with tamoxifen-containing chow markedly induced Cre-mediated recombination, yielding robust YFP labeling of Olig2-lineage cells. We previously reported that there were two types of Olig2-lineage cells in the adult brain (Tatsumi et al., 2008, 2016). The cell type with strong YFP fluorescence and bushy morphology were mature astrocytes (Tatsumi et al., 2016), and we confirmed that the bushy cells were positive for mature astrocyte markers in various brain regions, such as SOX9, S100β (Figures 1C1–C3, D1–D3, Figure S1) in the cerebral cortex, 3-PGDH (Figures 1E1–E3, Figure S1) in the facial nucleus (7N), GS (Figures 1F1–F3, Figure S1) in the subthalamic nucleus. The subcellular localization patterns varied among the mature markers; transcription factor SOX9 was found in the nucleus (Figure S1D), while the enzyme GS was primarily present in the cytoplasm, but was found little in the distal processes (Figure S1B). It should be noted that GS was distributed to the fine processes of Olig2-AS in addition to the cytoplasm in the cerebral cortex (Figure S1B; cx), but not in the other brain regions such as the globus pallidus or thalamus (Figure S1B; LGP, Th). The mechanisms underlying the differential subcellular distribution are unclear. The other type of YFP-positive cells was of oligodendrocyte lineage, including OPCs. We observed that mature oligodendrocyte marker CC-1 was positive in some of the YFP-expressing cells (Figures 1G1–G3, Figure S1), and immature oligodendrocyte marker NG2 was positive in other YFP-expressing cells (Figures 1H1–H3, Figure S1). The overall morphologies of these oligodendrocyte-lineage cells were clearly distinct from that of the bushy cells and these cells could not be detected in low magnification view, unless they were immunolabeled with anti-YFP antibody. This was most likely because polydendric processes were much simpler than bushy processes and the membrane-targeted YFP was less distributed in the oligodendrocyte-lineage cells. Taken together, the YFP-positive cells observed in low magnification view (Figure 1B) likely reflect the Olig2-lineage astrocytes.
Olig2-AS Express Low Level of GFAP
As mentioned above, Olig2-AS expressed several astrocytic markers (arrows, Figures 1, 2), but we noticed that Olig2-AS expressed low level of GFAP, the cardinal astrocytic marker. To confirm this notion, we performed double immunofluorescence study with YFP and various astrocytic markers including GFAP in Olig2CreER-Ai39 mice. Since GFAP immunoreactivity is not uniformly detected in the whole brain, we selected two regions, the lateral globus pallidus (LGP) and the substantia nigra (SN), where a number of GFAP-positive astrocytes exist. GFAP-positive cells co-expressed astrocytic markers such as SOX9 (arrowheads, Figures 2A2–A4), S100β (arrowheads, Figures 2B2–4,C2–C4) and GS (arrowheads, Figures 2D2–D4). On the other hand, Olig2-AS with bushy morphology also expressed astrocytic markers such as SOX9 (arrows, Figures 2A2,A4), S100β (arrows, Figures 2B2,B4,C2,C4) and GS (arrows, Figures 2D2,D4). We delineated territories of Olig2-AS with dotted line in the Figure 2 and even in the presence of GFAP-positive astrocytes, the Olig2-AS seldom overlapped with the GFAP-positive structures (Figures 2A3,B3,C3,D3).
In a low magnification view, Olig2-AS (YFP positive) were densely distributed in the LGP (Figure 3A1) and GFAP immunoreactivity was also strong (Figure 3A2). SOX9 positive cells were more widely observed in the LGP and the CPu (Figure 3A3). The orthogonal views (Figure 3B) and z-stack 3D images (Figure 3C) obtained with a confocal laser scanning microscope revealed that SOX9 positive Olig2-AS (arrows, Figures 3B,C) and SOX9 positive GFAP-positive astrocytes (arrowheads, Figures 3B,C) occupied adjacent but non-overlapping territories in the LGP. Semi-quantitative analyses revealed that 88% (204/232, n = 3) of SOX9-positive Olig2-AS were GFAP-negative and 12% (28/232, n = 3) of them co-expressed GFAP (Figure 3D). All of the SOX9-positive YFP-negative cells in the LGP co-expressed GFAP (281/281, n = 3) (Figure 3D). These findings illustrated that Olig2-AS constitute a sub-population of astrocytes distinct from GFAP-positive astrocytes.
The Distribution of Olig2-AS in the Adult Brain differs from That of GFAP-AS
Given the clear contrast in distribution patterns of Olig2-AS and GFAP-positive astrocytes, we mapped distribution of GFAP-positive astrocytes in the brain of GFAPCre-Ai39 mice and compared it with that of Olig2-AS. The GFAPCre-Ai39 mice showed strong YFP fluorescence in recombinant cells and the strong labeling was suitable for comparison with the strong fluorescence of Olig2-AS visualized after continuous oral administration of tamoxifen (see above). There is, however, a caveat: some of the recombinant cells may not be astrocytes but neurons in specific brain regions such as the OB and hippocampus, where neurogenesis takes place from GFAP-positive neuronal stem cells (Kempermann et al., 1997; Eriksson et al., 1998; Seri et al., 2001). In these regions, we additionally performed GFAP immunofluorescence to distinguish neurons from astrocytes (Figures S2A,B), since neurons quickly lose GFAP protein expression as they mature while astrocytes retain GFAP expression. The genetically labeled astrocytes in the GFAPCre-Ai39 mice are hereafter referred to as GFAP-astrocytes (GFAP-AS). Figures 4, 5 show low-magnification images of coronal brain sections of the same rostro-caudal position of both Olig2CreER−Ai39 mice and GFAPCre-Ai39 mice. As a reference for brain nuclei, we illustrated the corresponding section images (Figures 4A, 5A) and the borders of anatomical regions (Figures 4B,C, 5B,C) based on the atlas image according to the mouse brain map in stereotaxic coordinates (Franklin and Paxinos, 1997). In the following sections, we focus on the major brain regions where a significant difference was observed between Olig2-AS and GFAP-AS distribution. Regarding the densities of labeled cells in each brain region, we applied arbitrary criteria (strong, moderate and low/absent) (for classification details, see Materials and Methods) and summarize the distribution patterns of Olig2-AS and GFAP-AS in the Table 2.
Figure 5. Distribution patterns of Olig2-AS and GFAP-AS in the adult Olig2CreER- and GFAPCre-Ai39 mice (forebrain to brainstem). The brain images, corresponding illustrations (A1–A5), coronal images of Olig2CreER (B1–B5) and GFAPCre-Ai39 mice (C1–C5) with names of brain nuclei are presented as in this figure. Sections more caudal to those in this Figure 4 are shown.
Olfactory Bulb
It is well known that the OB has a multi-layered cellular architecture; these are the glomerular layer (GL), external plexiform layer (EPL), mitral cell layer (Mi), internal plexiform layer (IPL), and granule cell layer (GrL) in order from the surface to the core (Figure 4A1). As mention above, GFAP-positive neural progenitors originate and migrate from subventricular zone via the rostral migratory stream (Lois and Alvarez-Buylla, 1994). The YFP-positive cells, therefore, may be not only astrocytes but also neurons in GFAPCre-Ai39 mice. We therefore compared GFAP immunoreactivity with YFP fluorescence (Figures S2A1–A3). The GL, Mi, IPL and GrL were labeled strongly with GFAP antibody (Figure S2A2), but the immunoreaction in the EPL was weak (Figure S2A3). The labeling difference in the EPL suggested that the YFP fluorescence in this layer might be of the apical dendrites of inhibitory neurons in the GrL. Based on this finding, we considered that GFAP-AS was primarily distributed in the GL and IPL of the OB (Table 2). High densities of Olig2- AS were detected in the GL, EPL, and IPL (Figure 4B1).
Cerebral Cortex
Olig2-AS were evenly distributed in most areas of the cerebral cortex. Among these areas, dense distribution was found in the somatosensory area (S) (Figures 4B2–B5), especially in the barrel field (S1BF) (Figures 4B4,B5). In addition, it was also conspicuous in the prefrontal cortex (PFC) (Figure 4B2), motor area (Figures 4B2–B5), retrosplenial area (RS) (Figures 4B5, 5B1–B3), visual area (Figures 5B1–B3). GFAP-AS were evenly distributed in almost all the cortical areas (Figures 4C, 5C).
As for the cortical layers, Olig2-AS are densely distributed in the layers 2–5, but are sparse in the layers 1 and 6 (Figures S2C1,C2). In contrast to the Olig2-AS distribution, GFAP-AS are preferentially localized to the sub-pial region (layer 1) and form the glia-limitans in all cortical areas (Figures 4C2–C5, 5C1–C3, Figures S2C3,C4).
Striatum and Pallidum
We barely observed Olig2-AS in caudate-putamen (CPu) (Figures 4B3–B5) and accumbens nucleus (Acb) (Figure 4B3). In contrast, the lateral septal nucleus (LS) contained a high density of Olig2-AS (Figures 4B3,B4). GFAP-AS also accumulated densely in the LS and moderately in the CPu and Acb (Figure 4C3).
In the ventral pallidum (VP) area including the substantia innominata (SI) and the VP, a high density of Olig2-AS was observed (Figures 4B3,B4). As a result, these cells formed clear ventral borders of the CPu and Acb (Figures 4B3,B4). In the medial pallidum area including the medial septum nucleus (MS) and the diagonal band nucleus (NDB), Olig2-AS were also densely distributed (Figure 4B3). The NDB consists of an anteriorly located vertical limb (VDB), which branches posteriorly into separate bilateral horizontal limbs (HDB) (Herman et al., 2016). The high density of Olig2-AS distribution continued to the posterior HDB (Figure 4B4). In contrast, the density of GFAP-AS was low in the NDB (Figure 4C4) and the VP (Figures 4C3,C4). The globus pallidus is also known to belong to the dorsal pallidum, and consists of the LGP and the medial globus pallidus (MGP). Olig2-AS distribution was at a very high density in the LGP (Figure 4B5), and GFAP-AS density was also high in this nucleus (Figure 4C4). As mentioned above, however, GFAP-immunoreactive cells constitute a distinct population from Olig2-AS (Figures 2A,B, 3).
Thalamus and Hypothalamus
In most thalamic nuclei, the density of Olig2-AS was very high (Figures 4B5, 5B1,B2), and that of GFAP-AS was generally low except anterodorsal and anteroventral thalamic nuclei (AD and AV, respectively) (Figures 4C5, 5C1,C2). In an exceptional case, the medial habenular nucleus (MHb) showed an opposite pattern; a low density of Olig2-AS and high density of GFAP-AS were detected (Figures 5B1,C1, Figure S2D).
In the hypothalamus, both Olig2-AS and GFAP-AS were distributed in high or moderate densities (Figures 4B4,B5,C4,C5, 5B1,C1). It should be noted that GFAP-AS was scarce in the subthalamic nucleus (STh) (Figure 5C1) and the zona incerta (ZI) (Figure 5C2), while Olig2-AS was densely distributed in these nuclei (Figures 5B1,B2).
Hippocampus
Olig2-AS were localized in the CA3 region and in the polymorph layer of the dentate gyrus of the hippocampus (Figures 5B1–B3). In the CA1 and CA2 regions, Olig2-AS distribution was limited to the pyramidal cell layer. In contrast, GFAP-YFP expression in GFAPCre-Ai39 mice was confined to the molecular layer of the dentate gyrus (Figures 5C1–C3). It is well known that GFAP-positive neural stem cells generate neuroblasts and that the neuroblasts migrate to the granule layer, mature to become neurons and extend processes to the molecular layer (Lois and Alvarez-Buylla, 1994; Eriksson et al., 1998). Taking this into account, it is likely that GFAP-YFP signals found in the molecular layer was derived from neurons, but not from astrocytes. GFAP immunofluorescence in the hippocampus showed that GFAP-positive astrocytes were sparse in the molecular layer, discrepant from strong GFAP-YFP expression (Figure S2B). For this reason, we mapped distribution of GFAP-immunolabeled astrocytes, but not of GFAP-AS in the hippocampus (Table 2).
Midbrain and Pons
Olig2-AS were found at high density in most of the midbrain nuclei, but, in contrast, GFAP-AS were scarce (Figures 5B3–C3). Both types of astrocytes were, exceptionally, co-localized in the SN. However, as in the case of LGP (see above), Olig2-AS did not co-express GFAP immunoreactivity (Figures 2C,D).
In the pons, Olig2-AS were found at high density, especially in the principal sensory trigeminal nucleus (Pr5), motor trigeminal nucleus (Mo5) and olivary/periolivary nuclei (LSO, SPO, DPO, and MVPO) (Figure 5B4). In contrast, GFAP-AS were barely observed in these areas (Figure 5C4).
Medulla and Cerebellum
Olig2-AS were abundant throughout medulla nuclei. In particular, Olig2-AS were densely distributed in the spinal trigeminal nucleus (Sp5), facial nucleus (7N), and vestibular nuclei (VeN) (Figure 5B5). In contrast, GFAP-AS were observed at very low density in these regions. However, we observed strong expression of GFAP-YFP exceptionally in the cerebellar cortex, probably arising from the Bergmann glia (Figure 5C5).
In summary, the present mapping of two populations of astrocytes indicated a strong tendency for Olig2-AS and GFAP-AS to occupy different territories in the adult brain. Olig2-AS thus constitute a subpopulation of mature astrocytes and their distribution pattern implies functions specific to the various brain regions.
Olig2-AS Showed Very Similar Distribution Pattern to GAT3, but Not to Glutamate Transporters, GLT-1/GLAST
We reported previously that Olig2-AS expressed GAT-3 in the globus pallidus and the cerebral cortex (Tatsumi et al., 2016). In this study, we noticed that the whole brain distribution map of Olig2-AS was very similar to that of GAT-3 (Figures 6A,B, respectively). On the other hand, the glutamate transporters, GLT-1/GLAST distributions were much less overlapped with those of Olig2-AS (Figures 6A,C).
Figure 6. Olig2-AS distribution is similar to that of GAT-3, a GABA transporter. Low-magnification views of sagittal brain sections showed that the distribution of Olig2-AS (A) is similar to that of GAT-3 immunoreactivity, a glial GABA transporter (B), but not to that of glutamate transporters, GLT-1 and /or GLAST (C). Scale bar: 1 mm (C) for A,B).
Fine Processes of Olig2-AS Were Preferentially Associated with GABAergic Terminals in the LGP
The transporter expression patterns prompted us to examine the spatial relationships between fine processes of Olig2-AS and axon terminals of inhibitory or excitatory neurons. The double immunofluorescence experiments using anti-GFP antibody and anti-vesicular GABA transporter (VGAT) antibody or anti-vesicular glutamate transporters (VGluT1/2) antibodies were performed in the LGP of Olig2CreER -GFP mice (Figures 7A,B). The reason we chose the LGP is that the nucleus receives glutamatergic inputs from the subthalamic nucleus in addition to dense GABAergic inputs from the striatum (Kita and Kitai, 1987). We observed the strong expression of VGAT (Figure 7A2) and the moderate expression of VGluT1/T2 in the LGP (Figure 7B2) and Olig2-AS overlapped with both VGAT and VGluT1/2 immunoreactivities in the low magnification views (Figures 7A3,B3). At this light microscopic level, Olig2-AS appeared to be associated with both excitatory and inhibitory terminals, but the actual associations should be verified at an electron microscopic level. We therefore performed double immunoelectron microscopy with GFP and VGAT or VGluT1/2 antibodies in the Olig2CreER-GFP mice. We found that GFP-immunoreactive astrocytic processes (arrows, Figures 7C1,C2) tended to be associated with VGAT metal particle-labeled axon terminals (Figure 7C1, Tin), but not with VGluT1/2 metal particle-positive terminals (Figure 7C2, Tex). When we changed the labeling methods to the opposite way (axon terminals were labeled with GFP and astrocytic processes with metal particles), similar tendency was observed (Supplementary Figures S3A,B). We further observed the preferential association of astrocytic processes with GABAergic terminals in the cases that both astrocytic and neuronal elements were double-labeled with DAB (Figures 7D1,D2, Supplementary Figures S3C,D). Semi-quantitative analyses revealed that 56.8% (54/95, n = 3) of VGAT-immunoreactive terminals made contact with fine processes of Olig2-AS, while 15.4% (18/117, n = 3) of VGluT1/2 immunoreactive terminals did so (Figure 7E).
Figure 7. Fine processes of the Olig2-AS are closely associated with inhibitory terminals, but not with excitatory ones. (A,B) Low-magnification views of sections double-labeled with GFP and vesicular GABA transporter (VGAT) antibodies (A1,A2), with GFP and vesicular glutamate transporter (VGluT1/2) antibodies (B1,B2) in the LGP of Olig2CreER-GFP mice. The GFP immunoreaction overlapped with VGAT and VGluT1/2 immunoreactivity (A3,B3). (C) Double immunoelectron microscopic images with DAB reaction for GFP antibody and metal particle labeling for VGAT (C1) and VGluT1/2 (C2). GFP-immunoreactive Olig2-astrocytic processes (arrows) made contact with VGAT-immunoreactive axon terminals (C1, Tin). Olig2-astrocytic processes attached to an inhibitory terminal rather than metal particle-labeled excitatory terminal (C2, Tex). (D) Double immunoelectron microscopic images with DAB reactions for GFP antibody and for VGAT antibody (D1) or for VGluT1/2 antibodies (D2). Olig2-astrocytic processes (arrows) made contact preferentially to inhibitory terminals with VGAT-immunoreactivity. (E) Semi-quantitative analyses of axon terminals (inhibitory and excitatory) with or without contacts of GFP-positive astrocytic processes are shown. The percent ratio of the inhibitory terminals with process attachments to the total inhibitory terminals was 61.9 ± 18.4% (n = 3, attached terminals/total terminals; 15/37, 10/21, 29/37), while the ratio of the excitatory terminals with process attachments to the total excitatory terminals was 16.2 ± 4.39% (n = 3, attached terminals /total terminals; 9/46, 5/50, 4/21). The difference of the ratios was statistically significant (p = 0.016, one-way ANOVA with post-hoc tukey HSD test). Tin, inhibitory terminal; Tex, excitatory terminal; Dn, dendrite; Scale bar: 10 μm (B3, for A1,B2), 500 nm (D2, for C1,D1).
Discussion
Astrocytes are the most abundant glia cell type in the central nervous system (CNS) and they perform diverse functions in the brain. Accumulating evidence has revealed that astrocytes modulate synaptic activities by promoting neurotransmitter uptake from synaptic clefts and/or by releasing so-called gliotransmitters such as glutamate, D-serine, and ATP into synaptic clefts (Volterra and Meldolesi, 2005; Welberg, 2009). This type of modulation takes place in various brain regions and the concept of the tripartite synapse, consisting of pre- and post-synaptic neurons and astrocytic fine processes, has emerged and become widely accepted (Perea et al., 2009). In addition to the regulation of neurotransmission, astrocytic fine processes are implicated in synapse formation (Chung et al., 2015) and in formation of blood-brain barriers (Abbott et al., 2006). Such a variety of astrocytic functions suggests that there exist subtypes of astrocytes that play different roles. In line with this notion, the idea of astrocyte heterogeneity has attracted considerable interest (Bayraktar et al., 2015; Schitine et al., 2015). However, it is still an open question whether there are subpopulations specific for certain functions.
Cajal first divided astrocytes into two groups: fibrous astrocytes and protoplasmic astrocytes (Ramón y Cajal, 1897). This morphological classification corresponds to regional heterogeneity, because fibrous and protoplasmic astrocytes generally segregate in white matter and gray matter, respectively. Recent studies demonstrated that astrocytes are allocated to spatially distinct domains in the developing brain (Tsai et al., 2012; Molofsky et al., 2014; Bayraktar et al., 2015) and can only interact with neurons derived from the same domain (Torigoe et al., 2015). Given that astrocytic regional domains coordinate post-natal neural circuit formation and regulate eventual neuronal activity, astrocytic regional heterogeneity can also be regarded as functional heterogeneity. In our previous study, we reported that a subpopulation of astrocytes expressed a specific type of chondroitin sulfate proteoglycan (CSPG) recognized by CS56 monoclonal antibody (Hayashi et al., 2007). We identified the CSPG as tenascin-R (TNR) and the astrocytic population was distributed in the cerebral cortex of the various species, including human, primate, domestic pig and rodents. We further demonstrated that TNR regulated the expression of GLAST, a glutamate transporter, suggesting that the subset of astrocytes might be involved in the glutamate homeostasis in the cerebral cortex (Okuda et al., 2014).
With regard to regional heterogeneity, fluorescence-activated cell sorting (FACS) was recently applied to astrocytic classification (Zamanian et al., 2012; John Lin et al., 2017; Sun et al., 2017). John Lin et al. identified five distinct subpopulations from Aldh1l1-GFP transgenic adult mice (John Lin et al., 2017). They collected astrocytes from five different brain regions and compared the distribution of these subpopulations. They found that the most abundant subpopulation existed evenly in all regions and expressed synapse-related genes specifically, while another subpopulation clearly localized in certain specific regions. Interestingly, these subpopulations participated in the onset or progression of malignant glioma. These findings suggested that diverse astrocytic functions are provided by subpopulations not only under physiological conditions but also in the injury-disease state. Zamanian et al. profiled gene expression patterns in reactive astrocytes from Aldh1l1-GFP transgenic adult mice using the FACS technique (Zamanian et al., 2012). They showed that reactive astrocytes were highly heterogeneous in terms of gene expression patterns, and their transcriptome database generated the idea that there are broadly two subtypes of reactive astrocytes; furthermore, these two types were recently termed A1 and A2 astrocytes reminiscent of M1/M2 macrophages (Liddelow et al., 2017). The study demonstrated that A1 astrocytes were harmful for the surrounding microenvironment, and, on the contrary, that A2 astrocytes were beneficial for injured neuronal cells. Taken together, these recent reports strongly suggest that astrocytic subpopulations have differential roles in both physiological and pathological states.
In the present study, we suggest that the transcription factor Olig2 is involved in the formation of a subpopulation of astrocytes (Olig2-AS) in the adult brain. Olig2-AS have a distinct distribution pattern and express very low level of GFAP protein, although they express mature astrocytic markers such as S100β, GS, and 3-PGDH (Yamasaki et al., 2001). Immunoelectron microscopy demonstrated that Olig2-AS formed endfeet that were attached to brain capillaries (data not shown), also suggesting that Olig2-AS form blood-brain barrier, an important astrocytic function. We assume that astrocytes detected in other transgenic lines such as ALDH1L1-GFP mice also exert similar functions (Zamanian et al., 2012).
So far, several different types of GFAP-transgenic lines have been established (Brenner et al., 1994; Zhuo et al., 1997; Nolte et al., 2001; Casper and McCarthy, 2006; Lee et al., 2006). But the expression patterns of reporter proteins, for example GFP or lacZ, are not always consistent among these strains. GFAPCre mice we employed in the present study allowed detection of GFAP-expressing cells in a number of brain regions including subventricular zone (Imura et al., 2003). Neuronal stem cells are known to express GFAP (Kempermann et al., 1997; Eriksson et al., 1998; Seri et al., 2001) and in our GFAP immunofluorescence we indeed observed GFAP-immunoreactive neuronal processes in the EPL layer of the OB (Figure 2A2). Such different patterns of GFAP genetic labeling prompted a caution that the GFAP-AS detected in the present study may not cover all the GFAP-positive astrocytes. Interestingly, at least in the LGE and the SN, Olig2 genetic labeling combined with GFAP immunofluorescence demonstrated that two populations (Olig2-AS and GFAP-positive astrocytes) exhibited mutually-exclusive patterns of distributions (Figure 3). The reason why Olig2-AS expressed low level of GFAP is an open question.
In our previous report, we suggested that Olig2 astrocytes are subsidiary to inhibitory GABAergic transmission (Tatsumi et al., 2016). The present mapping of Olig2-AS in the adult brain and comparison with that of astrocytic GABA transporter reinforced this idea. The current members of GABA transporter family are GAT-1, -2, and -3. GAT-1 is primarily expressed in GABAergic neurons and is involved in GABA uptake from synaptic clefts. GAT-2 and -3 are of glial subtypes and GAT-3 is the dominant type between two (Zhou and Danbolt, 2013). Interestingly, a recent report demonstrated that astrocytes could release GABA by the reverse action of GAT-2 or -3 (Héja et al., 2012). Olig2-AS may also exert inhibitory functions with the reverse action of GAT-3. We further demonstrated that fine processes of Olig2-AS preferentially made contact with terminals of VGAT-positive axons rather than VGluT1/2-positive excitatory ones in the LGP. A caveat to this result is that the LGP receives more inhibitory inputs than excitatory ones (see Figures 7A2,B2) and the chance of astrocytic contacts to the excitatory terminals might be hampered. However, in the present study, we chose the territories of Olig2-AS, where the GFP-positive fine processes are enriched. In these fields, we picked up comparable numbers of inhibitory terminals (total number 95 from three animals) and excitatory terminals (total number 117 from three animals), but we detected significant difference in the numbers of astrocytic process-attached terminals (inhibitory; 54 out of 95, excitatory; 18 out of 117). The difference can contradict the caveat. We do not know whether the preferential contacts of Olig2-AS to inhibitory terminals can be observed in other brain regions and what kind of astrocytes compensate for the lack of contacts to excitatory terminals. These are intriguing questions for future studies. The morphological observation under an electron microscope provides strong circumstantial evidence and it is tempting to speculate that there may be a subpopulation of astrocytes that is specific to certain neurotransmitters. This kind of heterogeneity may be barely detectable if one isolates and compares astrocytes from two or more brain regions (Zamanian et al., 2012; John Lin et al., 2017). The hypothesis appears to be compatible with the idea that astrocytes and neurons derived from the same domain of the embryonic brain can only interact each with each other (Torigoe et al., 2015), because GABAergic interneurons arise from Olig2-expressing precursors (Miyoshi et al., 2007). However, whether Olig2-AS in the adult brain really arise from Olig2-positive precursors and regulate GABA transmission awaits further studies. The developmental origin and lineage tracing of Olig2-AS are thus critical in providing an answer to the hypothesis and are currently under investigation.
Author Contributions
KT designed research; KT, AI, MY, SM-T, YK, KN, YT, TS, HO, and TT performed research; KT and AW analyzed data and wrote the paper.
Funding
This work was supported by JSPS KAKENHI Grant Numbers 15K06743 [Scientific Research (C)], 15K14354 (Exploratory Research), 26830029 [Young Scientists (B)] and 26293039 [Scientific Research (B)], and by the Takeda Science Foundation (JJ12010029).
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
We thank Prof. Hirohide Takebayashi (Niigata University, Japan) and Prof. Katsuhiko Ono (Kyoto Prefectural University, Japan) for providing us with Olig2CreER knock-in mice, and Dr. Tetsuya Imura (Fukushima Medical University, Japan) for providing with GFAPCre knock-in mice. We also thank Prof. Masahiko Watanabe (Hokkaido University, Japan) for kind suggestion for immunoelectron microscopy.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnana.2018.00008/full#supplementary-material
Abbreviations
3-PGDH, rabbit anti-3-phosphoglycerate dehydrogenase; MS, medial septum nucleus; 7N, facial nucleus; Mve, medial vestibular nucleus; Acb, accumbens nucleus; NDB, diagonal band nucleus; AD, anterodorsal thalamic nucleus; OPT, olivary pretectal nucleus; AV, anteroventral thalamic nucleus; PaPo, paraventricular hypothalamic nucleus, posterior part; AH, anterior hypothalamic area; PaV, paraventricular hypothalamic nucleus, ventral part; AM, anteromedial thalamic nucleus; PF, parafascicular thalamic nucleus; APT, anterior pretectal nucleus; PFC, prefrontal cortex; BMP, basomedial amygdaloid nucleusposterior part; PH, posterior hypothalamic area; BST, bed nucleus of the stria terminals; Pir, piriform cortex; CbX, cerebellar cortex; PMCo, posterior cortical amygaloid nucleus; Cg/RS, cingulate retrosplenial cortex; Pn, Pontine nuclei; CM, central medial thalamic nucleus; Po, posterior thalamic nuclear group; Cpu, caudla putamen; PPT, posterior pretectal nucleus; DCN, deep cerebellar nuclei Pr5 principal sensory trigeminal nucleus; DG, dentate gyrus; PV, paraventricular thalamic nucleus; DpMe, deep mesencephalic nucleus; RSA, retrosplenial agranular cortex; EPL, external plexiform layer; RSG, retrosplenial granular; GL, glomerular laye; Rt, reticular thalamic nucleus; GrDG, dentate gyrus, granule cell layer; S, somatosensory cortex; GrL, granular cell layer; S100β, S100 calcium-binding protein B; GS, glutamine synthetase; S1BF, primary somatosensory cortex, barrel field; HY, Hypothalamus; SC, superior colliculus; IC, inferior colliculus; SCh, suprachiasmatic nucleus; LGP, lateral globus pallidus; SI, substantia innominate; LH, lateral hypothalamic nucleus; SN, substantia nigra; LHb, lateral habenular nucleus; Son, superior olivary nuclei; LP, lateral thalamic nucleuar group; Sp5, spinal trigeminal nucleus; LPO, lateral preoptic area; Spa, subparaventricular zone of the hypothalamus; LSD, lateral septal nucleus, dorsal part; SpVe, spinal vestibular nucleus; LSI, lateral septal nucleus, intermediate; STh, subthalamic nucleus; LV, lateral ventricle; SuVe, superior vestibular nucleus; M, motor cortex; Th, Thalamus; MD, mediodorsal thalamic nucleus; V1, V2, visual cortex; MG, medial geniculate nucleus; VA, ventral anterior thalamic nucleus; MG, medial geniculate nucleus; VeCb, vestibulocerebellar nucleus; MHb, medial habenular nucleus; vGluT1, vesicular glutamine transporteranti-1; Mi, mitral cell layer; vGluT2, vesicular glutamine transporteranti-2; MM, Mammillary body; VLG, ventral lateral geniculate nucleus; Mo5, motor trigeminal nucleus; VP, Ventral pallidun; MPA, medial preoptic area; VPL, ventral posterolateral thalamic nucleus; MPO, medial preoptic nucleus; VPM, ventral posteromedial thalamic nucleus; MPT, medial pretectal nucleus; ZI, zona incerta.
References
Abbott, N. J., Rönnbäck, L., and Hansson, E. (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41–53. doi: 10.1038/nrn1824
Bayraktar, O. A., Fuentealba, L. C., Alvarez-Buylla, A., and Rowitch, D. H. (2015). Astrocyte development and heterogeneity. Cold Spring Harb. Perspect. Biol. 7:a020362. doi: 10.1101/cshperspect.a020362
Brenner, M., Kisseberth, W. C., Su, Y., Besnard, F., and Messing, A. (1994). GFAP promoter directs astrocyte-specific expression in transgenic mice. J. Neurosci. 14, 1030–1037.
Cali, C., Lopatar, J., Petrelli, F., Pucci, L., and Bezzi, P. (2014). G-protein coupled receptor-evoked glutamate exocytosis from astrocytes: role of prostaglandins. Neural Plast. 2014:254574. doi: 10.1155/2014/254574
Casanova, E., Fehsenfeld, S., Lemberger, T., Shimshek, D. R., Sprengel, R., and Mantamadiotis, T. (2002). ER-based double icre fusion protein allows partial recombination in forebrain. Genesis 34, 208–214. doi: 10.1002/gene.10153
Casper, K. B., and McCarthy, K. D. (2006). GFAP-positive progenitor cells produce neurons and oligodendrocytes throughout the CNS. Mol. Cell. Neurosci. 31, 676–684. doi: 10.1016/j.mcn.2005.12.006
Chaudhry, F. A., Lehre, K. P., Van Lookeren Campagne, M., Ottersen, O. P., Danbolt, N. C., and Storm-Mathisen, J. (1995). Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 15, 711–720. doi: 10.1016/0896-6273(95)90158-2
Chung, W.-S., Allen, N. J., and Eroglu, C. (2015). astrocytes control synapse formation, function, and elimination. Cold Spring Harb. Perspect. Biol. 7:a020370. doi: 10.1101/cshperspect.a020370
Dimou, L., Simon, C., Kirchhoff, F., Takebayashi, H., and Götz, M. (2008). Progeny of Olig2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex. J. Neurosci. 28, 10434–10442. doi: 10.1523/JNEUROSCI.2831-08.2008
Durkin, M. M., Smith, K. E., Borden, L. A., Weinshank, R. L., Branchek, T. A., and Gustafson, E. L. (1995). Localization of messenger RNAs encoding three GABA transporters in rat brain: an in situ hybridization study. Mol. Brain Res. 33, 7–21. doi: 10.1016/0169-328X(95)00101-W
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., et al. (1998). Neurogenesis in the adult human hippocampus. Nat. Med. 4, 1313–1317. doi: 10.1038/3305
Feil, S., Valtcheva, N., and Feil, R. (2009). “Inducible cre mice,” in Gene Knockout Protocols, 2nd Edn., eds W. Wurst and R. Kühn (Totowa, NJ: Humana Press), 343–363.
Fiacco, T. A., and McCarthy, K. D. (2018). Multiple lines of evidence indicate that gliotransmission does not occur under physiological conditions. J. Neurosci. 38, 3–13. doi: 10.1523/JNEUROSCI.0016-17.2017
Franklin, K. B. J., and Paxinos, G. (1997). The Mouse Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press.
Fraser, D. D., Mudrick-Donnon, L. A., and Macvicar, B. A. (1994). Astrocytic GABA receptors. Glia 11, 83–93. doi: 10.1002/glia.440110203
Fukuda, S., Kondo, T., Takebayashi, H., and Taga, T. (2004). Negative regulatory effect of an oligodendrocytic bHLH factor OLIG2 on the astrocytic differentiation pathway. Cell Death Differ. 11, 196–202. doi: 10.1038/sj.cdd.4401332
Galvan, A., Hu, X., Smith, Y., and Wichmann, T. (2010). Localization and function of GABA transporters in the globus pallidus of parkinsonian monkeys. Exp. Neurol. 223, 505–515. doi: 10.1016/j.expneurol.2010.01.018
Garcia, A. D., Doan, N. B., Imura, T., Bush, T. G., and Sofroniew, M. V. (2004). GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat. Neurosci. 7, 1233–1241. doi: 10.1038/nn1340
Goldman, S. (2003). Glia as neural progenitor cells. Trends Neurosci. 26, 590–596. doi: 10.1016/j.tins.2003.09.011
Guo, F., Maeda, Y., Ma, J., Delgado, M., Sohn, J., Miers, L., et al. (2011). Macroglial plasticity and the origins of reactive astroglia in experimental autoimmune encephalomyelitis. J. Neurosci. 31, 11914–11928. doi: 10.1523/JNEUROSCI.1759-11.2011
Hayashi, N., Tatsumi, K., Okuda, H., Yoshikawa, M., Ishizaka, S., Miyata, S., et al. (2007). DACS, novel matrix structure composed of chondroitin sulfate proteoglycan in the brain. Biochem. Biophys. Res. Commun. 364, 410–415. doi: 10.1016/j.bbrc.2007.10.040
Haydon, P. G. (2001). Glia: listening and talking to the synapse. Nat. Rev. Neurosci. 2:185. doi: 10.1038/35058528
Héja, L., Nyitrai, G., Kékesi, O., Dobolyi, A., Szabó, P., Fiáth, R., et al. (2012). Astrocytes convert network excitation to tonic inhibition of neurons. BMC Biol. 10:26. doi: 10.1186/1741-7007-10-26
Herman, A. M., Ortiz-Guzman, J., Kochukov, M., Herman, I., Quast, K. B., Patel, J. M., et al. (2016). A cholinergic basal forebrain feeding circuit modulates appetite suppression. Nature 538, 253–256. doi: 10.1038/nature19789
Herrmann, J. E., Imura, T., Song, B., Qi, J., Ao, Y., Nguyen, T. K., et al. (2008). STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J. Neurosci. 28, 7231–7243. doi: 10.1523/JNEUROSCI.1709-08.2008
Imura, T., Kornblum, H. I., and Sofroniew, M. V. (2003). The predominant neural stem cell isolated from postnatal and adult forebrain but not early embryonic forebrain expresses GFAP. J. Neurosci. 23, 2824–2832.
Islam, M. S., Tatsumi, K., Okuda, H., Shiosaka, S., and Wanaka, A. (2009). Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions. Neurochem. Int. 54, 192–198. doi: 10.1016/j.neuint.2008.10.011
Jin, X. T., Galvan, A., Wichmann, T., and Smith, Y. (2011a). Localization and function of GABA transporters GAT-1 and GAT-3 in the basal ganglia. Front. Syst. Neurosci. 5:63. doi: 10.3389/fnsys.2011.00063
Jin, X. T., Paré, J. F., and Smith, Y. (2011b). Differential localization and function of GABA transporters, GAT-1 and GAT-3, in the rat globus pallidus. Eur. J. Neurosci. 33, 1504–1518. doi: 10.1111/j.1460-9568.2011.07636.x
John Lin, C.-C., Yu, K., Hatcher, A., Huang, T.-W., Lee, H. K., Carlson, J., et al. (2017). Identification of diverse astrocyte populations and their malignant analogs. Nat. Neurosci. 20, 396–405. doi: 10.1038/nn.4493
Kempermann, G., Kuhn, H. G., and Gage, F. H. (1997). Genetic influence on neurogenesis in the dentate gyrus of adult mice. Proc. Natl. Acad. Sci. U.S.A. 94, 10409–10414. doi: 10.1073/pnas.94.19.10409
Kiermayer, C., Conrad, M., Schneider, M., Schmidt, J., and Brielmeier, M. (2007). Optimization of spatiotemporal gene inactivation in mouse heart by oral application of tamoxifen citrate. Genesis 45, 11–16. doi: 10.1002/dvg.20244
Kirmse, K., Kirischuk, S., and Grantyn, R. (2009). Role of GABA transporter 3 in GABAergic synaptic transmission at striatal output neurons. Synapse 63, 921–929. doi: 10.1002/syn.20675
Kita, H., and Kitai, S. T. (1987). Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with the PHA-L method. J. Comp. Neurol. 260, 435–452. doi: 10.1002/cne.902600309
Lee, S., Yoon, B. E., Berglund, K., Oh, S. J., Park, H., Shin, H. S., et al. (2010). Channel-mediated tonic GABA release from glia. Science 330, 790–796. doi: 10.1126/science.1184334
Lee, Y., Su, M., Messing, A., and Brenner, M. (2006). Astrocyte heterogeneity revealed by expression of a GFAP-LacZ transgene. Glia 53, 677–687. doi: 10.1002/glia.20320
Liang, X., Lu, Y., Neubert, T. A., and Resh, M. D. (2002). Mass spectrometric analysis of GAP-43/neuromodulin reveals the presence of a variety of fatty acylated species. J. Biol. Chem. 277, 33032–33040. doi: 10.1074/jbc.M204607200
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., et al. (2017). Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481–487. doi: 10.1038/nature21029
Lois, C., and Alvarez-Buylla, A. (1994). Long-distance neuronal migration in the adult mammalian brain. Science 264, 1145–1148. doi: 10.1126/science.8178174
Madisen, L., Mao, T., Koch, H., Zhuo, J.-M., Berenyi, A., Fujisawa, S., et al. (2012). A toolbox of Cre-dependent optogenetic transgenic mice for light-induced activation and silencing. Nat. Neurosci. 15:793. doi: 10.1038/nn.3078
Madisen, L., Zwingman, T. A., Sunkin, S. M., Oh, S. W., Zariwala, H. A., Gu, H., et al. (2009). A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13:133. doi: 10.1038/nn.2467
Magnus, T., Carmen, J., Deleon, J., Xue, H., Pardo, A. C., Lepore, A. C., et al. (2008). Adult glial precursor proliferation in mutant SOD1G93A mice. Glia 56, 200–208. doi: 10.1002/glia.20604
Minelli, A., Debiasi, S., Brecha, N. C., Zuccarello, L. V., and Conti, F. (1996). GAT-3, a high-affinity GABA plasma membrane transporter, is localized to astrocytic processes, and it is not confined to the vicinity of GABAergic synapses in the cerebral cortex. J. Neurosci. 16, 6255–6264.
Miyazaki, T., Fukaya, M., Shimizu, H., and Watanabe, M. (2003). Subtype switching of vesicular glutamate transporters at parallel fibre–Purkinje cell synapses in developing mouse cerebellum. Eur. J. Neurosci. 17, 2563–2572. doi: 10.1046/j.1460-9568.2003.02698.x
Miyoshi, G., Butt, S. J., Takebayashi, H., and Fishell, G. (2007). Physiologically distinct temporal cohorts of cortical interneurons arise from telencephalic Olig2-expressing precursors. J. Neurosci. 27, 7786–7798. doi: 10.1523/JNEUROSCI.1807-07.2007
Molofsky, A. V., Kelley, K. W., Tsai, H. H., Redmond, S. A., Chang, S. M., Madireddy, L., et al. (2014). Astrocyte-encoded positional cues maintain sensorimotor circuit integrity. Nature 509, 189–194. doi: 10.1038/nature13161
Nolte, C., Matyash, M., Pivneva, T., Schipke, C. G., Ohlemeyer, C., Hanisch, U. K., et al. (2001). GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue. Glia 33, 72–86. doi: 10.1002/1098-1136(20010101)33:1<72::AID-GLIA1007>3.0.CO;2-A
Okuda, H., Tatsumi, K., Morita, S., Shibukawa, Y., Korekane, H., Horii-Hayashi, N., et al. (2014). Chondroitin sulfate proteoglycan tenascin-R regulates glutamate uptake by adult brain astrocytes. J. Biol. Chem. 289, 2620–2631. doi: 10.1074/jbc.M113.504787
Ono, K., Takebayashi, H., Ikeda, K., Furusho, M., Nishizawa, T., Watanabe, K., et al. (2008). Regional- and temporal-dependent changes in the differentiation of Olig2 progenitors in the forebrain, and the impact on astrocyte development in the dorsal pallium. Dev. Biol. 320, 456–468. doi: 10.1016/j.ydbio.2008.06.001
Parras, C. M., Hunt, C., Sugimori, M., Nakafuku, M., Rowitch, D., and Guillemot, F. (2007). The proneural gene Mash1 specifies an early population of telencephalic oligodendrocytes. J. Neurosci. 27, 4233–4242. doi: 10.1523/JNEUROSCI.0126-07.2007
Perea, G., Navarrete, M., and Araque, A. (2009). Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci. 32, 421–431. doi: 10.1016/j.tins.2009.05.001
Petryniak, M. A., Potter, G. B., Rowitch, D. H., and Rubenstein, J. L. (2007). Dlx1 and Dlx2 control neuronal versus oligodendroglial cell fate acquisition in the developing forebrain. Neuron 55, 417–433. doi: 10.1016/j.neuron.2007.06.036
Ramón y Cajal, S. (1897). Las células de cilindro-eje corto de la capa molecular del cerebro. Rev. Trim. Micrográfica. 2, 153–162.
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., et al. (1996). Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675–686. doi: 10.1016/S0896-6273(00)80086-0
Savtchouk, I., and Volterra, A. (2018). Gliotransmission: beyond black-and-white. J. Neurosci. 38, 14–25. doi: 10.1523/JNEUROSCI.0017-17.2017
Schitine, C., Nogaroli, L., Costa, M. R., and Hedin-Pereira, C. (2015). Astrocyte heterogeneity in the brain: from development to disease. Front. Cell. Neurosci. 9:76. doi: 10.3389/fncel.2015.00076
Seri, B., García-Verdugo, J. M., McEwen, B. S., and Alvarez-Buylla, A. (2001). Astrocytes give rise to new neurons in the adult mammalian hippocampus. The Journal of Neuroscience 21, 7153–7160.
Setoguchi, T., and Kondo, T. (2004). Nuclear export of OLIG2 in neural stem cells is essential for ciliary neurotrophic factor-induced astrocyte differentiation. J. Cell Biol. 166, 963–968. doi: 10.1083/jcb.200404104
Shimizu, T., Tanaka, K. F., Takebayashi, H., Higashi, M., Wisesmith, W., Ono, K., et al. (2013). Olig2-lineage cells preferentially differentiate into oligodendrocytes but their processes degenerate at the chronic demyelinating stage of proteolipid protein-overexpressing mouse. J. Neurosci. Res. 91, 178–186. doi: 10.1002/jnr.23153
Soriano, P. (1999). Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21, 70–71. doi: 10.1038/5007
Sun, W., Cornwell, A., Li, J., Peng, S., Osorio, M. J., Su Wanga, N. A., et al. (2017). SOX9 is an astrocyte-specific nuclear marker in the adult brain outside the neurogenic regions. J. Neurosci. 37, 4493–4507. doi: 10.1523/JNEUROSCI.3199-16.2017
Takasaki, C., Yamasaki, M., Uchigashima, M., Konno, K., Yanagawa, Y., and Watanabe, M. (2010). Cytochemical and cytological properties of perineuronal oligodendrocytes in the mouse cortex. Eur. J. Neurosci. 32, 1326–1336. doi: 10.1111/j.1460-9568.2010.07377.x
Takebayashi, H., Nabeshima, Y., Yoshida, S., Chisaka, O., Ikenaka, K., and Nabeshima, Y. (2002). The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages. Curr. Biol. 12, 1157–1163. doi: 10.1016/S0960-9822(02)00926-0
Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., et al. (1997). Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276, 1699–1702. doi: 10.1126/science.276.5319.1699
Tatsumi, K., Okuda, H., Morita-Takemura, S., Tanaka, T., Isonishi, A., Shinjo, T., et al. (2016). Voluntary exercise induces astrocytic structural plasticity in the globus pallidus. Front. Cell. Neurosci. 10:165. doi: 10.3389/fncel.2016.00165
Tatsumi, K., Takebayashi, H., Manabe, T., Tanaka, K. F., Makinodan, M., Yamauchi, T., et al. (2008). Genetic fate mapping of Olig2 progenitors in the injured adult cerebral cortex reveals preferential differentiation into astrocytes. J. Neurosci. Res. 86, 3494–3502. doi: 10.1002/jnr.21862
Torigoe, M., Yamauchi, K., Zhu, Y., Kobayashi, H., and Murakami, F. (2015). Association of astrocytes with neurons and astrocytes derived from distinct progenitor domains in the subpallium. Sci. Rep. 5:12258. doi: 10.1038/srep12258
Tsai, H. H., Li, H., Fuentealba, L. C., Molofsky, A. V., Taveira-Marques, R., Zhuang, H., et al. (2012). Regional astrocyte allocation regulates CNS synaptogenesis and repair. Science 337, 358–362. doi: 10.1126/science.1222381
Volterra, A., and Meldolesi, J. (2005). Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 6, 626–640. doi: 10.1038/nrn1722
Welberg, L. (2009). Neuron-glia interactions: glia make waves. Nat. Rev. Neurosci. 10, 695–695. doi: 10.1038/nrn2724
Welle, S., Burgess, K., Thornton, C. A., and Tawil, R. (2009). Relation between extent of myostatin depletion and muscle growth in mature mice. Am. J. Physiol. Endocrinol. Metab. 297, E935–E940. doi: 10.1152/ajpendo.00179.2009
Yamasaki, M., Matsui, M., and Watanabe, M. (2010). Preferential localization of muscarinic M1 receptor on dendritic shaft and spine of cortical pyramidal cells and its anatomical evidence for volume transmission. J. Neurosci. 30, 4408–4418. doi: 10.1523/JNEUROSCI.5719-09.2010
Yamasaki, M., Yamada, K., Furuya, S., Mitoma, J., Hirabayashi, Y., and Watanabe, M. (2001). 3-Phosphoglycerate dehydrogenase, a key enzyme for l-Serine biosynthesis, is preferentially expressed in the radial glia/astrocyte lineage and olfactory ensheathing glia in the mouse brain. J. Neurosci. 21, 7691–7704.
Zamanian, J. L., Xu, L., Foo, L. C., Nouri, N., Zhou, L., Giffard, R. G., et al. (2012). Genomic analysis of reactive astrogliosis. J. Neurosci. 32, 6391–6410. doi: 10.1523/JNEUROSCI.6221-11.2012
Zhao, J. W., Raha-Chowdhury, R., Fawcett, J. W., and Watts, C. (2009). Astrocytes and oligodendrocytes can be generated from NG2+ progenitors after acute brain injury: intracellular localization of oligodendrocyte transcription factor 2 is associated with their fate choice. Eur. J. Neurosci. 29, 1853–1869. doi: 10.1111/j.1460-9568.2009.06736.x
Zhou, Q., and Anderson, D. J. (2002). The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 109, 61–73. doi: 10.1016/S0092-8674(02)00677-3
Zhou, Y., and Danbolt, N. (2013). GABA and glutamate transporters in brain. Front. Endocrinol. 4:165. doi: 10.3389/fendo.2013.00165
Keywords: Olig2, GFAP, astrocyte, heterogeneity, GABA
Citation: Tatsumi K, Isonishi A, Yamasaki M, Kawabe Y, Morita-Takemura S, Nakahara K, Terada Y, Shinjo T, Okuda H, Tanaka T and Wanaka A (2018) Olig2-Lineage Astrocytes: A Distinct Subtype of Astrocytes That Differs from GFAP Astrocytes. Front. Neuroanat. 12:8. doi: 10.3389/fnana.2018.00008
Received: 29 September 2017; Accepted: 19 January 2018;
Published: 14 February 2018.
Edited by:
Corrado Calì, King Abdullah University of Science and Technology, Saudi ArabiaReviewed by:
João Filipe Oliveira, University of Minho, PortugalFrancesco Petrelli, University of Lausanne, Switzerland
Maura Francolini, Università degli Studi di Milano, Italy
Copyright © 2018 Tatsumi, Isonishi, Yamasaki, Kawabe, Morita-Takemura, Nakahara, Terada, Shinjo, Okuda, Tanaka and Wanaka. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Kouko Tatsumi, cmFkaGE4MTVAbmFyYW1lZC11LmFjLmpw